Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GALT · against 396 other Healthcare companies of similar size
Ranked #368 of 397 · scores higher than 7% of peers · safety percentile 8
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)42 peers with a safety percentile of 0–9, including GALT · Click a bar to see the companies
Mainly because of its current ratio and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GALT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 364 reported | Not reported | 0.19× | — | — | 33% |
| BetaLower is better · 382 reported | 0.39 | 0.46 | 56% | 33% | |
| Current ratioHigher is better · 390 reported | 0.10× | 3.01× | 0% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 261M USD | 99 | 97 | |
| 4 | 397M USD | 99 | 37 | |
| 5 | 455M USD | 99 | 53 | |
| 364 | 296M USD | 8 | 26 | |
| 365 | 2.1B CNY (≈$291M) | 8 | 9 | |
| 366 | 303M USD | 8 | 27 | |
| 367 | 2.3B CNY (≈$322M) | 8 | 10 | |
| 368 | 338M USD | 8 | ||
| 369 | 504M USD | 8 | 24 | |
| 370 | 251M EUR (≈$276M) | 7 | 52 | |
| 371 | 2.9B CNY (≈$412M) | 7 | 22 | |
| 372 | 334M USD | 7 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score